CSL Licenses Antibodies From Aussie Newcomer Patrys
This article was originally published in The Pink Sheet Daily
Executive Summary
Most companies start target first, antibody second, but Patrys identifies antibodies that human beings naturally make and then looks for those that kill cancer cells.